Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Sequestration Impact: Training, Standards And Reg Science

This article was originally published in The Gray Sheet

Executive Summary

CDRH Director Jeffrey Shuren detailed last week how federal sequestration cuts to FDA are impacting specific device center programs, including training, standards development and regulatory science. Shuren also signaled imminent policy releases from the center, including a finalized post-market surveillance plan.

You may also be interested in...



Industry Encouraged By FDA Fulfillment Of MDUFA 2013 Goals

AdvaMed is pleased FDA met its review and performance goals for fiscal year 2013 as outlined in the October 2012 medical device user fee agreement.

Industry Encouraged By FDA Fulfillment Of MDUFA 2013 Goals

AdvaMed is pleased FDA met its review and performance goals for fiscal year 2013 as outlined in the October 2012 medical device user fee agreement.

Shuren To Lawmakers: Sequestration Is “Killing Us”

CDRH Director Jeffrey Shuren fears the center won’t be able to meet commitments to hire new employees for FY 2014 if the sequester continues, he told members of the House Energy & Commerce Health Subcommittee last week.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel